氯吡格雷联合小剂量尿激酶在进展性脑梗死中的临床效果观察

李斌永

（西乡县人民医院神经内科，陕西 汉中，723500）

浏览次数：87次 下载次数：325次

摘要：

目的 观察氯吡格雷联合小剂量尿激酶治疗进展性脑梗死的临床效果及对患者神经功能、生活质量的影响。方法 将80例进展性脑梗死患者随机分为对照组和观察组，每组40例。对照组采用常规方法联合小剂量尿激酶治疗，观察组在对照组的基础上，给予氯吡格雷治疗。比较两组治疗效果，治疗前、后神经功能和生活质量改善情况及不良反应发生情况。结果 观察组的总有效率为95.0%，明显高于对照组的75.0%（P<0.05）。观察组治疗后神经功能缺损评分与日常生活能力评分显著优于对照组（P<0.05）。两组不良反应总发生率比较，差异无统计学意义（P>0.05）。结论 氯吡格雷联合小剂量尿激酶治疗进展性脑梗死可显著改善预后，降低神经损伤程度，值得临床推广应用。

关键词：氯吡格雷；尿激酶；进展性脑梗死

中图分类号：R743文献标志码：A文章编号：2096-1413(2017)12-0049-02

Clinical observation of clopidogrel combined with low-dose urokinase in progressive cerebral infarction
LI Bin-yong
（Department of Neurology, People s Hospital of Xixiang County, Hanzhong 723500, China）

ABSTRACT: Objective To observe the clinical effect of clopidogrel combined with low-dose urokinase and its influence on patients nerve function, quality of life in patient with progressive cerebral infarction. Methods Eighty patients with progressive cerebral infarction were randomly divided into control group and observation group, with 40 cases in each group. The control group was treated with routine therapy in combination with small dose of urokinase, while the observation group was treated with clopidogrel on the basis of the control group. The treatment effect, neural function and quality of life before and after treatment, the incidence of adverse reaction in the two groups were compared. Results The total effective rate of the observation group was 95.0%, which was significantly higher than 75.0% of the control group, the difference was statistically significant (P <0.05). The scores of neurological deficit and the daily life ability of the observation group were significantly better than those of the control group (P<0.05). The incidence of adverse reactions was statistically analyzed, and the difference was not statistically significant (P>0.05). Conclusion Clopidogrel in combination with small dose of urokinase in treatment of progress cerebral infarction can significantly improve the prognosis, reduce the degree of nerve injury, which is worthy of clinical popularization and application.
KEYWORDS: clopidogrel; urokinase; progressive cerebral infarction

参考文献：
[1] 赵汝旺.氯吡格雷与小剂量尿激酶联合治疗急性进展性脑梗死疗效分析[J].中国实用医药,2015,10(33):22-23.
[2] 陈彩虹.奥扎格雷钠联合灯盏细辛治疗进展性脑梗死的临床效果观察[J].中国当代医药,2014,21(6):73-75.
[3] 顾亮亮.氯吡格雷与尤瑞克林联合应用治疗进展性脑梗死41例临床疗效观察[J].中国实用医药,2011,6(35):174-175.
[4] 安鑫,苏娜,赵建本,等.氯吡格雷联合阿司匹林治疗进展性脑梗死的临床观察[J].齐齐哈尔医学院学报,2016,37(13):1700-1701.
[5] 耿纪超,陈攸.早期小剂量甘露醇治疗进展性脑梗死的临床观察[J].中国实用医药,2009,4(32):30-31.
[6] 段海平,胡雅坤,孙丽萍,等.小剂量尿激酶联合双抗血小板治疗进展性脑梗死的临床观察[J].中国伤残医学,2014,22(1):117-118.
[7] 黄美彩.小剂量尿激酶与奥扎格雷钠联合治疗进展性脑梗死的有效性及安全性分析[J].海峡药学,2015,27(7):109-110.
[8] 潘更毅,张宪秋,胡伟盛,等.氯吡格雷与小剂量尿激酶联合治疗急性进展性脑梗死疗效观察[J].中国实用神经疾病杂志,2008,11(1):59-61.
[9] 缑元冲,牛晓波,段贺春,等.小剂量尿激酶联合氯吡格雷治疗进展性脑梗死疗效观察[J].中国实用医药,2016,11(24):121-123.
[10] 胡午辉,丁玲.阿加曲班治疗进展性脑梗死疗效观察[J].卒中与神经疾病,2011,18(3):184-186.